Compound News and Research

RSS

Researchers discover potential method to identify TBI using positron PET scans

Accurately diagnosing traumatic brain injuries (TBI) and concussions is difficult, as standard CT or MRI scans can't see most changes to the brain caused by these injuries.

24 Oct 2013

Biocompatible compounds can be used to develop customized implant designs with 3-D printing

Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and Laser Zentrum Hannover have discovered that a naturally-occurring compound can be incorporated into three-dimensional (3-D) printing processes to create medical implants out of non-toxic polymers.

24 Oct 2013

IPM receives US$40M from USAID to advance new HIV prevention tools for women

The International Partnership for Microbicides (IPM) announced today that it has received two competitive five-year awards with a combined US$40 million ceiling from the US Agency for International Development (USAID).

23 Oct 2013

NeuroAiD reduces early cardiovascular events and deaths by 50% after stroke onset

NeuroAiD™, a treatment of post-stroke recovery containing natural extracts, reduces early cardiovascular events and deaths by nearly 50% on top of antiplatelet agents within three months after stroke onset, without an increase in bleeding rate and non-vascular deaths according to research published online in the journal Stroke.

22 Oct 2013

Nanopharmaceutical drug shows promise for cancers that resist antiangiogenic drugs

The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.

22 Oct 2013

Shorter sleep duration, poorer sleep quality may impact Alzheimer's disease onset and progression

Poor sleep quality may impact Alzheimer's disease onset and progression. This is according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health who examined the association between sleep variables and a biomarker for Alzheimer's disease in older adults.

22 Oct 2013

Anergis reports immunology data from AllerT Phase IIb study for birch pollen allergy

Anergis, a company focusing on proprietary allergy vaccines, today reported immunology data from the Phase IIb study of its lead compound AllerT.

21 Oct 2013

New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer

LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.

21 Oct 2013

NIH Getting Back To Business As Shutdown Ends

...

17 Oct 2013

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

...

17 Oct 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.

17 Oct 2013

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

...

16 Oct 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

Researchers test ATR-101 compound in clinical trial for adrenal cancer

One of the most challenging cancers to treat is also one of the rarest, which only adds to the challenge of finding potential new therapies.

16 Oct 2013

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

An international team of scientists have identified potentially dangerous amounts of methamphetamine analog in the workout supplement Craze, a product widely sold across the U.S. and online.

15 Oct 2013

DIM compound derived from cruciferous vegetable protects rodents from radiation doses

Georgetown University Medical Center researchers say a compound derived from cruciferous vegetable such as cabbage, cauliflower and broccoli protected rats and mice from lethal doses of radiation.

15 Oct 2013

Football-shaped artificial particles teach immune cells to recognize, destroy cancer cells

Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching immune cells to recognize and destroy cancer cells in mice.

14 Oct 2013

Blood test can help predict which bipolar patients will benefit from Ketamine

Researchers have discovered how to determine which bipolar patients will benefit from Ketamine, a treatment commonly used for depression and pain relief, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Resveratrol can make tumor cells more susceptible to radiation treatment

A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment. This research, which studied melanoma cells, follows a previous MU study that found similar results in the treatment of prostate cancer.

12 Oct 2013

Scientists decode key molecular gateway for toxin that causes botulism

U.S. and German scientists have decoded a key molecular gateway for the toxin that causes botulism, pointing the way to treatments that can keep the food-borne poison out of the bloodstream.

12 Oct 2013

Compound News and Research

Researchers discover potential method to identify TBI using positron PET scans

Biocompatible compounds can be used to develop customized implant designs with 3-D printing

IPM receives US$40M from USAID to advance new HIV prevention tools for women

NeuroAiD reduces early cardiovascular events and deaths by 50% after stroke onset

Nanopharmaceutical drug shows promise for cancers that resist antiangiogenic drugs

Shorter sleep duration, poorer sleep quality may impact Alzheimer's disease onset and progression

Anergis reports immunology data from AllerT Phase IIb study for birch pollen allergy

New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer

NIH Getting Back To Business As Shutdown Ends

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

New type of antibiotic kills multidrug-resistant germ common to health care settings

Researchers test ATR-101 compound in clinical trial for adrenal cancer

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

DIM compound derived from cruciferous vegetable protects rodents from radiation doses

Football-shaped artificial particles teach immune cells to recognize, destroy cancer cells

Blood test can help predict which bipolar patients will benefit from Ketamine

Resveratrol can make tumor cells more susceptible to radiation treatment

Scientists decode key molecular gateway for toxin that causes botulism

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News